International Biotechnology (UK) Performance
| IBT Stock | 633.00 5.00 0.78% |
The company retains a Market Volatility (i.e., Beta) of 0.4, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, International Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding International Biotechnology is expected to be smaller as well. At this point, International Biotechnology has a negative expected return of -0.11%. Please make sure to check out International Biotechnology's daily balance of power, market facilitation index, and the relationship between the kurtosis and day median price , to decide if International Biotechnology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days International Biotechnology Trust has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Forward Dividend Yield 0.0464 | Forward Dividend Rate 0.3 | Ex Dividend Date 2024-12-19 |
1 | International Biotechnology Trust Manager Update Themes for 2025 - Research Tree | 01/09/2025 |
2 | International Biotechnology Stock Crosses Above 200-Day Moving Average - Heres What Happened - MarketBeat | 01/24/2025 |
3 | Investing in biotechnology with investment trusts - Feb 2025 Investor - Kepler Trust Intelligence | 02/26/2025 |
4 | Six ISA trust picks for all tastes - FE Trustnet | 03/19/2025 |
| Begin Period Cash Flow | -32.5 M |
International |
International Biotechnology Relative Risk vs. Return Landscape
If you would invest 68,400 in International Biotechnology Trust on December 30, 2024 and sell it today you would lose (5,100) from holding International Biotechnology Trust or give up 7.46% of portfolio value over 90 days. International Biotechnology Trust is generating negative expected returns and assumes 1.1327% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than International, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
International Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for International Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as International Biotechnology Trust, and traders can use it to determine the average amount a International Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0996
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IBT |
Estimated Market Risk
| 1.13 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average International Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of International Biotechnology by adding International Biotechnology to a well-diversified portfolio.
International Biotechnology Fundamentals Growth
International Stock prices reflect investors' perceptions of the future prospects and financial health of International Biotechnology, and International Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on International Stock performance.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0806 | ||||
| Profit Margin | 0.91 % | ||||
| Operating Margin | 1.00 % | ||||
| Current Valuation | 248.58 M | ||||
| Shares Outstanding | 35.39 M | ||||
| Price To Book | 0.79 X | ||||
| Price To Sales | 6.02 X | ||||
| Revenue | 40.14 M | ||||
| Gross Profit | 42.88 M | ||||
| EBITDA | 39.55 M | ||||
| Net Income | 38.88 M | ||||
| Total Debt | 22.83 M | ||||
| Book Value Per Share | 7.66 X | ||||
| Cash Flow From Operations | 45.35 M | ||||
| Earnings Per Share | 1.02 X | ||||
| Total Asset | 308.15 M | ||||
| Retained Earnings | (54.03 M) | ||||
About International Biotechnology Performance
By analyzing International Biotechnology's fundamental ratios, stakeholders can gain valuable insights into International Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if International Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if International Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
International Biotechnology is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about International Biotechnology performance evaluation
Checking the ongoing alerts about International Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for International Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| International Biotechnology generated a negative expected return over the last 90 days | |
| International Biotechnology is unlikely to experience financial distress in the next 2 years | |
| Latest headline from news.google.com: Six ISA trust picks for all tastes - FE Trustnet |
- Analyzing International Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether International Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining International Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating International Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of International Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of International Biotechnology's stock. These opinions can provide insight into International Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for International Stock analysis
When running International Biotechnology's price analysis, check to measure International Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy International Biotechnology is operating at the current time. Most of International Biotechnology's value examination focuses on studying past and present price action to predict the probability of International Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move International Biotechnology's price. Additionally, you may evaluate how the addition of International Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |